Patient-derived Models: A Promising Frontier in Testing the Efficacy of Drugs for Bladder Cancer

Eur Urol. 2024 Nov;86(5):445-446. doi: 10.1016/j.eururo.2024.08.020. Epub 2024 Aug 25.

Authors

Henning Plage¹, Franz F Dressler², Annika Fendler³

Affiliations

¹ Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
² Institute of Pathology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
³ Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. Electronic address: [email protected].

PMID: 39183091
DOI: 10.1016/j.eururo.2024.08.020

No abstract available

Publication types

Editorial